Frazier Life Sciences Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
1,734,601
+798,025
| +85% | +$5.73M | 0.5% | 36 |
|
|
2025
Q1 | $5.61M | Hold |
936,576
| – | – | 0.26% | 41 |
|
|
2024
Q4 | $7.31M | Hold |
936,576
| – | – | 0.3% | 42 |
|
|
2024
Q3 | $10.1M | Hold |
936,576
| – | – | 0.41% | 38 |
|
|
2024
Q2 | $7.9M | Hold |
936,576
| – | – | 0.37% | 39 |
|
|
2024
Q1 | $6.29M | Sell |
936,576
-1,058,691
| -53% | -$7.11M | 0.27% | 43 |
|
|
2023
Q4 | $11.7M | Buy |
1,995,267
+493,884
| +33% | +$2.9M | 0.63% | 39 |
|
|
2023
Q3 | $14.6M | Hold |
1,501,383
| – | – | 0.97% | 25 |
|
|
2023
Q2 | $17.8M | Sell |
1,501,383
-657,771
| -30% | -$7.79M | 1.06% | 23 |
|
|
2023
Q1 | $23.3M | Buy |
2,159,154
+50,000
| +2% | +$540K | 1.69% | 13 |
|
|
2022
Q4 | $24.4M | Buy |
2,109,154
+35,000
| +2% | +$405K | 1.52% | 18 |
|
|
2022
Q3 | $30.9M | Sell |
2,074,154
-20,000
| -1% | -$298K | 2.38% | 11 |
|
|
2022
Q2 | $18.9M | Sell |
2,094,154
-557,600
| -21% | -$5.03M | 1.78% | 15 |
|
|
2022
Q1 | $19.9M | Buy |
+2,651,754
| New | +$19.9M | 1.69% | 19 |
|